You searched for lung cancer | Page 7 of 152

Median Technologies Completes FDA Q-Submission Phase for Lung Cancer Screening Software

Posted by Andy Lundin | Feb 27, 2023 | Lung Cancer |

The Q-submission phase is a regulatory step which allows regular and in-depth discussions with the FDA on key topics.

Posted by Andy Lundin | Feb 24, 2023 | Lung Cancer |

Lucence announced that Palmetto GBA finalized a foundational local coverage determination (LCD) for the LiquidHALLMARKassay.

Posted by Andy Lundin | Sep 7, 2022 | Lung Cancer |

Implementing lung cancer screening at four diverse healthcare systems resulted in a 6.6% decrease in Stage IV disease.

Posted by Chris Wolski | Jul 13, 2022 | Lung Cancer |

Researchers have found a blood biomarker that can complement LDCT by distinguishing NSCLC from benign nodules without an invasive biopsy.

Medial EarlySign signed a new partnership with Roche to create innovative, evidence-based solutions for early detection of lung cancer.